Do analysts recommend EBON or TNFA?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ebang International 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 TNF Pharmaceuticals 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better earnings & valuation, EBON or TNFA?

Ebang International has higher revenue and earnings than TNF Pharmaceuticals. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Ebang International $6.54M 2.22 -$14.09M N/A N/A TNF Pharmaceuticals N/A N/A -$23.36M -$231.00 N/A

Is EBON or TNFA more profitable?

Ebang International's return on equity of 0.00% beat TNF Pharmaceuticals' return on equity. Company Net Margins Return on Equity Return on Assets Ebang International N/A N/A N/A TNF Pharmaceuticals N/A -69.21% -33.98%

Do analysts recommend TNFA or AIMD?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score TNF Pharmaceuticals 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Ainos 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is TNFA or AIMD more profitable?

TNF Pharmaceuticals has a net margin of 0.00% compared to Ainos' net margin of -11,912.10%. TNF Pharmaceuticals' return on equity of -69.21% beat Ainos' return on equity. Company Net Margins Return on Equity Return on Assets TNF Pharmaceuticals N/A -69.21% -33.98% Ainos -11,912.10% -217.50% -67.87%

Do analysts prefer BOXL or TNFA?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Boxlight 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 TNF Pharmaceuticals 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts recommend TNFA or AGMH?

AGM Group has a consensus target price of $5.77, suggesting a potential upside of 548.24%. Given AGM Group's higher probable upside, analysts clearly believe AGM Group is more favorable than TNF Pharmaceuticals. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score TNF Pharmaceuticals 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 AGM Group 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable earnings and valuation, TNFA or AGMH?

AGM Group has higher revenue and earnings than TNF Pharmaceuticals. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio TNF Pharmaceuticals N/A N/A -$23.36M -$231.00 N/A AGM Group $30.56M 0.09 $560K N/A N/A

Is TNFA or AGMH more profitable?

AGM Group's return on equity of 0.00% beat TNF Pharmaceuticals' return on equity. Company Net Margins Return on Equity Return on Assets TNF Pharmaceuticals N/A -69.21% -33.98% AGM Group N/A N/A N/A

Do analysts recommend AIMDW or TNFA?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ainos 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 TNF Pharmaceuticals 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better valuation & earnings, AIMDW or TNFA?

Ainos has higher revenue and earnings than TNF Pharmaceuticals. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Ainos $13.60K N/A N/A N/A N/A TNF Pharmaceuticals N/A N/A -$23.36M -$231.00 N/A

Is AIMDW or TNFA more profitable?

Ainos' return on equity of 0.00% beat TNF Pharmaceuticals' return on equity. Company Net Margins Return on Equity Return on Assets Ainos N/A N/A N/A TNF Pharmaceuticals N/A -69.21% -33.98%

TNF Pharmaceuticals (TNFA) Competitors

$1.91 -0.18 (-8.61%)

As of 09/2/2026

Compare

TNFA vs. EBON, AIMD, BOXL, AGMH, and AIMDW

Should you buy TNF Pharmaceuticals stock or one of its competitors? TNF Pharmaceuticals's main competitors and comparable companies include Ebang International (EBON), Ainos (AIMD), Boxlight (BOXL), AGM Group (AGMH), and Ainos (AIMDW). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "technology hardware, storage & peripherals" industry.

How does TNF Pharmaceuticals compare to Ebang International?

Ebang International (NASDAQ:EBON) and TNF Pharmaceuticals (NASDAQ:TNFA) are both small-cap technology companies, but which is the superior business? We will contrast the two businesses based on the strength of their media sentiment, earnings, dividends, profitability, institutional ownership, risk, analyst recommendations and valuation.

In the previous week, Ebang International's average media sentiment score of 0.00 beat TNF Pharmaceuticals' score of -0.67 indicating that Ebang International is being referred to more favorably in the media.

Company	Overall Sentiment
Ebang International	Neutral
TNF Pharmaceuticals	Negative

Ebang International has a beta of 2.99, suggesting that its stock price is 199% more volatile than the broader market. Comparatively, TNF Pharmaceuticals has a beta of 2.04, suggesting that its stock price is 104% more volatile than the broader market.

Ebang International has higher revenue and earnings than TNF Pharmaceuticals.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ebang International	$6.54M	2.22	-$14.09M	N/A	N/A
TNF Pharmaceuticals	N/A	N/A	-$23.36M	-$231.00	N/A

1.2% of Ebang International shares are owned by institutional investors. Comparatively, 9.6% of TNF Pharmaceuticals shares are owned by institutional investors. 25.4% of Ebang International shares are owned by insiders. Comparatively, 0.5% of TNF Pharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Ebang International's return on equity of 0.00% beat TNF Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Ebang International	N/A	N/A	N/A
TNF Pharmaceuticals	N/A	-69.21%	-33.98%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ebang International	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
TNF Pharmaceuticals	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Ebang International beats TNF Pharmaceuticals on 7 of the 8 factors compared between the two stocks.

How does TNF Pharmaceuticals compare to Ainos?

TNF Pharmaceuticals (NASDAQ:TNFA) and Ainos (NASDAQ:AIMD) are both small-cap technology companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, valuation, analyst recommendations, media sentiment, risk, dividends, profitability and institutional ownership.

TNF Pharmaceuticals has a net margin of 0.00% compared to Ainos' net margin of -11,912.10%. TNF Pharmaceuticals' return on equity of -69.21% beat Ainos' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
TNF Pharmaceuticals	N/A	-69.21%	-33.98%
Ainos	-11,912.10%	-217.50%	-67.87%

TNF Pharmaceuticals has a beta of 2.04, suggesting that its share price is 104% more volatile than the broader market. Comparatively, Ainos has a beta of 2.47, suggesting that its share price is 147% more volatile than the broader market.

In the previous week, Ainos had 1 more articles in the media than TNF Pharmaceuticals. MarketBeat recorded 1 mentions for Ainos and 0 mentions for TNF Pharmaceuticals. Ainos' average media sentiment score of 0.00 beat TNF Pharmaceuticals' score of -0.67 indicating that Ainos is being referred to more favorably in the news media.

Company	Overall Sentiment
TNF Pharmaceuticals	Negative
Ainos	Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
TNF Pharmaceuticals	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Ainos	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Ainos has higher revenue and earnings than TNF Pharmaceuticals. Ainos is trading at a lower price-to-earnings ratio than TNF Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
TNF Pharmaceuticals	N/A	N/A	-$23.36M	-$231.00	N/A
Ainos	$120K	95.94	-$14.77M	-$2.52	N/A

9.6% of TNF Pharmaceuticals shares are held by institutional investors. 0.5% of TNF Pharmaceuticals shares are held by insiders. Comparatively, 9.8% of Ainos shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Summary

Ainos beats TNF Pharmaceuticals on 7 of the 12 factors compared between the two stocks.

How does TNF Pharmaceuticals compare to Boxlight?

Boxlight (NASDAQ:BOXL) and TNF Pharmaceuticals (NASDAQ:TNFA) are both small-cap technology companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, risk, analyst recommendations, valuation, institutional ownership, profitability and media sentiment.

TNF Pharmaceuticals has a net margin of 0.00% compared to Boxlight's net margin of -20.96%. Boxlight's return on equity of 0.00% beat TNF Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Boxlight	-20.96%	N/A	-23.50%
TNF Pharmaceuticals	N/A	-69.21%	-33.98%

In the previous week, Boxlight had 1 more articles in the media than TNF Pharmaceuticals. MarketBeat recorded 1 mentions for Boxlight and 0 mentions for TNF Pharmaceuticals. Boxlight's average media sentiment score of 1.39 beat TNF Pharmaceuticals' score of -0.67 indicating that Boxlight is being referred to more favorably in the media.

Company	Overall Sentiment
Boxlight	Positive
TNF Pharmaceuticals	Negative

TNF Pharmaceuticals has lower revenue, but higher earnings than Boxlight. Boxlight is trading at a lower price-to-earnings ratio than TNF Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Boxlight	$109.25M	0.04	-$23.81M	-$80.86	N/A
TNF Pharmaceuticals	N/A	N/A	-$23.36M	-$231.00	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Boxlight	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
TNF Pharmaceuticals	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Boxlight has a beta of 0.9, indicating that its stock price is 10% less volatile than the broader market. Comparatively, TNF Pharmaceuticals has a beta of 2.04, indicating that its stock price is 104% more volatile than the broader market.

6.5% of Boxlight shares are held by institutional investors. Comparatively, 9.6% of TNF Pharmaceuticals shares are held by institutional investors. 15.4% of Boxlight shares are held by company insiders. Comparatively, 0.5% of TNF Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Summary

Boxlight beats TNF Pharmaceuticals on 7 of the 12 factors compared between the two stocks.

How does TNF Pharmaceuticals compare to AGM Group?

TNF Pharmaceuticals (NASDAQ:TNFA) and AGM Group (NASDAQ:AGMH) are both small-cap technology companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, risk, media sentiment, institutional ownership, earnings, valuation and profitability.

In the previous week, AGM Group had 2 more articles in the media than TNF Pharmaceuticals. MarketBeat recorded 2 mentions for AGM Group and 0 mentions for TNF Pharmaceuticals. AGM Group's average media sentiment score of 1.34 beat TNF Pharmaceuticals' score of -0.67 indicating that AGM Group is being referred to more favorably in the news media.

Company	Overall Sentiment
TNF Pharmaceuticals	Negative
AGM Group	Positive

TNF Pharmaceuticals has a beta of 2.04, meaning that its stock price is 104% more volatile than the broader market. Comparatively, AGM Group has a beta of 2.52, meaning that its stock price is 152% more volatile than the broader market.

AGM Group's return on equity of 0.00% beat TNF Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
TNF Pharmaceuticals	N/A	-69.21%	-33.98%
AGM Group	N/A	N/A	N/A

AGM Group has higher revenue and earnings than TNF Pharmaceuticals.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
TNF Pharmaceuticals	N/A	N/A	-$23.36M	-$231.00	N/A
AGM Group	$30.56M	0.09	$560K	N/A	N/A

9.6% of TNF Pharmaceuticals shares are held by institutional investors. 0.5% of TNF Pharmaceuticals shares are held by insiders. Comparatively, 34.9% of AGM Group shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

AGM Group has a consensus target price of $5.77, suggesting a potential upside of 548.24%. Given AGM Group's higher probable upside, analysts clearly believe AGM Group is more favorable than TNF Pharmaceuticals.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
TNF Pharmaceuticals	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
AGM Group	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

AGM Group beats TNF Pharmaceuticals on 9 of the 10 factors compared between the two stocks.

How does TNF Pharmaceuticals compare to Ainos?

Ainos (NASDAQ:AIMDW) and TNF Pharmaceuticals (NASDAQ:TNFA) are both technology companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, valuation, institutional ownership, earnings, profitability, risk, analyst recommendations and dividends.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ainos	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
TNF Pharmaceuticals	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Ainos' average media sentiment score of 0.00 beat TNF Pharmaceuticals' score of -0.67 indicating that Ainos is being referred to more favorably in the media.

Company	Overall Sentiment
Ainos	Neutral
TNF Pharmaceuticals	Negative

Ainos' return on equity of 0.00% beat TNF Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Ainos	N/A	N/A	N/A
TNF Pharmaceuticals	N/A	-69.21%	-33.98%

Ainos has higher revenue and earnings than TNF Pharmaceuticals.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ainos	$13.60K	N/A	N/A	N/A	N/A
TNF Pharmaceuticals	N/A	N/A	-$23.36M	-$231.00	N/A

9.6% of TNF Pharmaceuticals shares are owned by institutional investors. 0.5% of TNF Pharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

Ainos beats TNF Pharmaceuticals on 4 of the 7 factors compared between the two stocks.

Get TNF Pharmaceuticals News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TNFA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

TNFA vs. The Competition

Export

Metric	TNF Pharmaceuticals	Technology Hardware, Storage & Peripherals Industry	Technology Sector	NASDAQ Exchange
Market Cap	$3.53M	$118.05B	$29.51B	$12.73B
Dividend Yield	N/A	1.68%	2.73%	8.86%
P/E Ratio	-0.01	28.49	75.77	25.25
Price / Sales	N/A	87.20	592.15	97.66
Price / Cash	N/A	20.13	47.32	52.26
Price / Book	0.01	7.63	9.29	6.14
Net Income	-$23.36M	$3.57B	$678.51M	$349.01M
7 Day Performance	-19.41%	-0.04%	-0.79%	-0.31%
1 Month Performance	-30.55%	3.85%	-0.97%	0.64%
1 Year Performance	-47.09%	90.71%	185.96%	14.83%

TNF Pharmaceuticals Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
TNFA TNF Pharmaceuticals	0.0575 of 5 stars	$1.91 -8.6%	N/A	-45.1%	$3.53M	N/A	N/A	6	Gap Down
EBON Ebang International	0.39 of 5 stars	$2.23 -3.0%	N/A	-48.1%	$15.02M	$6.54M	N/A	260	Gap Down
AIMD Ainos	0.4995 of 5 stars	$1.45 +4.3%	N/A	-58.3%	$10.26M	$120K	N/A	40	Gap Up
BOXL Boxlight	0.3553 of 5 stars	$6.49 +18.6%	N/A	-90.1%	$3.65M	$109.25M	N/A	180	Gap Down
AGMH AGM Group	1.878 of 5 stars	$1.08 +2.9%	$5.77 +434.3%	-52.4%	$3.39M	$30.56M	N/A	20	News Coverage Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:TNFA) was last updated on 9/4/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

TNF Pharmaceuticals (TNFA) Competitors

TNFA vs. EBON, AIMD, BOXL, AGMH, and AIMDW

How does TNF Pharmaceuticals compare to Ebang International?

Summary

How does TNF Pharmaceuticals compare to Ainos?

Summary

How does TNF Pharmaceuticals compare to Boxlight?

Summary

How does TNF Pharmaceuticals compare to AGM Group?

Summary

How does TNF Pharmaceuticals compare to Ainos?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TNFA vs. The Competition

TNF Pharmaceuticals Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

TNF Pharmaceuticals (TNFA) Competitors

TNFA vs. EBON, AIMD, BOXL, AGMH, and AIMDW

How does TNF Pharmaceuticals compare to Ebang International?

Does the media refer more to EBON or TNFA?

Which has more risk & volatility, EBON or TNFA?

Which has better earnings & valuation, EBON or TNFA?

Do insiders and institutionals hold more shares of EBON or TNFA?

Is EBON or TNFA more profitable?

Do analysts recommend EBON or TNFA?

Summary

How does TNF Pharmaceuticals compare to Ainos?

Is TNFA or AIMD more profitable?

Which has more risk and volatility, TNFA or AIMD?

Does the media refer more to TNFA or AIMD?

Do analysts recommend TNFA or AIMD?

Which has preferable earnings & valuation, TNFA or AIMD?

Do institutionals and insiders have more ownership in TNFA or AIMD?

Summary

How does TNF Pharmaceuticals compare to Boxlight?

Is BOXL or TNFA more profitable?

Does the media favor BOXL or TNFA?

Which has better valuation & earnings, BOXL or TNFA?

Do analysts prefer BOXL or TNFA?

Which has more volatility and risk, BOXL or TNFA?

Do insiders and institutionals hold more shares of BOXL or TNFA?

Summary

How does TNF Pharmaceuticals compare to AGM Group?

Does the media refer more to TNFA or AGMH?

Which has more volatility & risk, TNFA or AGMH?

Is TNFA or AGMH more profitable?

Which has preferable earnings and valuation, TNFA or AGMH?

Do insiders & institutionals hold more shares of TNFA or AGMH?

Do analysts recommend TNFA or AGMH?

Summary

How does TNF Pharmaceuticals compare to Ainos?

Do analysts recommend AIMDW or TNFA?

Does the media prefer AIMDW or TNFA?

Is AIMDW or TNFA more profitable?

Which has better valuation & earnings, AIMDW or TNFA?

Do insiders and institutionals believe in AIMDW or TNFA?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TNFA vs. The Competition

TNF Pharmaceuticals Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools